Therapy Areas: Respiratory
Orano Med and Roche advance pretargeted radioimmunotherapy into clinical phase
4 December 2025 - Orano Med, a subsidiary of the Orano group with a focus on nuclear medicine, announced on Thursday that its collaboration with Swiss biotechnology company Roche (SIX: RO, ROG; OTCQX:...
bioMérieux launches equine endocrinology tests to expand point-of-care diagnostics
4 December 2025 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Thursday that it has introduced two equine endocrinology immunoassays -- VIDAS Equine INSULIN and VIDAS...
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
4 December 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) confirmed on Thursday that it has completed its acquisition of UK biotechnology company Vicebio Ltd, adding an...
Neola Medical secures US patent for disposable lung monitoring probes
2 December 2025 - Medical technology company Neola Medical AB (NASDAQ First North Growth Market:NEOLA) said on Tuesday that it has been granted a US patent for its disposable probes used with the Neol...
Spinogenix reports approval of 'tazbentetol' as non-proprietary name for SPG302
2 December 2025 - Clinical-stage pharmaceutical company Spinogenix Inc announced on Monday that it has received approval from the International Nonproprietary Names (INN) Expert Committee of the World...
Polarean expands XENOVIEW 3T Coil access with Philips compatibility
1 December 2025 - Medical imaging technology company Polarean Imaging plc (AIM: POLX) reported on Monday that its FDA-cleared XENOVIEW 3T Chest Coil has passed Philips' compatibility testing, con...